PCENABL Stock Latest News
Private CompaniesEnable Injections Highlights Large-Volume Subcutaneous Delivery Potential3h agoENABL
Private CompaniesEnable Injections Targets Manufacturing Leadership to Support Production Growth1w agoENABL
Private CompaniesLarge-Volume Subcutaneous Delivery Platform Targets Pharma Development Flexibility1w agoENABL
Private CompaniesEnable Injections Highlights On-Body Delivery Platform for Large-Volume SC Therapies2w agoENABL
Private CompaniesEnable Injections Targets Industry Visibility at Pharma Customer Engagement 20263w agoENABL
Private CompaniesEnable Injections Highlights Potential Shift in Large-Volume Subcutaneous Drug Delivery4w agoENABLPrivate CompaniesEnable Injections Highlights enFuse Technology at Pharma Customer Engagement Conference1M agoENABL
Private CompaniesOn-Body Drug Delivery Platform Aligns With Shift From IV to Subcutaneous Therapies1M agoENABL
Private CompaniesExecutive Recognition Underscores Enable Injections’ Focus on Drug Delivery Innovation1M agoENABL
Private CompaniesEnable Injections Engages in Oncology Technology-Biology Forum1M agoENABL
Private CompaniesEnable Injections Highlights On-Body Drug Delivery Focus at PDA 2026 Conference1M agoENABL
Private CompaniesNeedle-Free Experience Emphasized in Enable Injections’ Drug-Delivery Design1M agoENABLPrivate CompaniesEnable Injections Executive to Join Industry Webinar on Oncology Technology1M agoENABL
Private CompaniesNeedle-Design Features Spotlight Enable Injections’ enFuse Drug Delivery System1M agoENABL
Private CompaniesEnable Injections Targets Talent Expansion Through Co-op Hiring1M agoENABL
Private CompaniesEnable Injections Inc – Weekly Recap2M agoENABL
Private CompaniesEnable Injections Showcases enFuse Platform at PDA Drug Delivery Conference2M agoENABL
Private CompaniesReassessing Subcutaneous Drug Volume Limits in Injectable Drug Development2M agoENABL
Private CompaniesNeedle Design Focus Underscores Enable Injections’ Patient-Centric Device Strategy2M agoENABLPrivate CompaniesEnable Injections Highlights Regulatory Momentum for On-Body Drug Delivery Technology2M agoENABL
Private CompaniesPatient-Centric Design Emphasized in Enable Injections’ Drug Delivery System2M agoENABL



